F. René-Corail

发表

Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.

J. Bertherat, X. Bertagna, C. Cavard, 2005, Cancer research.

IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma

E. Baudin, J. Bertherat, X. Bertagna, 2014, PloS one.

DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.

A. Tabarin, E. Korpershoek, E. Baudin, 2016, The Journal of clinical endocrinology and metabolism.

Phosphodiesterase 11A (PDE11A) and Genetic Predisposition to Adrenocortical Tumors

J. Bertherat, X. Bertagna, C. Stratakis, 2008, Clinical Cancer Research.

Somatic TP53 Mutations Are Relatively Rare among Adrenocortical Cancers with the Frequent 17p13 Loss of Heterozygosity

C. Elie, J. Bertherat, X. Bertagna, 2007, Clinical Cancer Research.

Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.

J. Bertherat, X. Bertagna, C. Stratakis, 2009, The Journal of clinical endocrinology and metabolism.

Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.

J. Bertherat, G. Assié, O. Chabre, 2010, The Journal of clinical endocrinology and metabolism.

Differential Expression of Parathyroid Hormone–Related Protein in Adrenocortical Tumors: Autocrine/Paracrine Effects on the Growth and Signaling Pathways in H295R Cells

J. Bertherat, X. Bertagna, G. Assié, 2008, Cancer Epidemiology Biomarkers & Prevention.

Role of the Transcription Factor CREB (cAMP Response Element Binding Protein) in Endocrine Tissue Development and Tumorigenesis

J. Bertherat, X. Bertagna, E. Jullian, 2003 .

Integrated genomic characterization of adrenocortical carcinoma

Eric Baudin, Martin Fassnacht, Franco Mantero, 2014, Nature Genetics.

Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors.

J. Bertherat, C. Stratakis, A. Horvath, 2012, The Journal of clinical endocrinology and metabolism.

Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.

Bertrand Dousset, Aurélien de Reyniès, D. Rickman, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical and pathophysiological implications of chromosomal alterations in adrenocortical tumors: an integrated genomic approach.

J. Bertherat, X. Bertagna, G. Assié, 2012, The Journal of clinical endocrinology and metabolism.

Mutations and polymorphisms in the gene encoding regulatory subunit type 1‐alpha of protein kinase A (PRKAR1A): an update

E. Remmers, F. Faucz, J. Bertherat, 2010, Human mutation.

Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.

P. Chanson, J. Bertherat, X. Bertagna, 2007, European journal of endocrinology.

A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds.

P. Chanson, J. Bertherat, X. Bertagna, 2006, The Journal of clinical endocrinology and metabolism.

Adrenal Pathophysiology: Lessons from the Carney Complex

J. Bertherat, L. Groussin, E. Jullian, 2005, Hormone Research in Paediatrics.

Identification of a CpG island methylator phenotype in adrenocortical carcinomas.

J. Bertherat, X. Bertagna, G. Assié, 2013, The Journal of clinical endocrinology and metabolism.

Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.

J. Bertherat, X. Bertagna, F. Tissier, 2010, The Journal of clinical endocrinology and metabolism.

Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.

J. Bertherat, X. Bertagna, G. Assié, 2014, European journal of endocrinology.

ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome.

M. Sibony, J. Bertherat, X. Bertagna, 2013, The New England journal of medicine.

Identification of gene expression profiles associated with cortisol secretion in adrenocortical adenomas.

J. Bertherat, G. Assié, A. de Reyniès, 2013, The Journal of clinical endocrinology and metabolism.

ARMC 5 Mutations in Macronodular Adrenal Hyperplasia with Cushing ’ s Syndrome

M. Sibony, J. Bertherat, X. Bertagna, 2013 .

[Pigmented micronodular dysplasia of the adrenal glands and Carney complex].

J. Bertherat, X. Bertagna, E. Jullian, 2005, Annales d'endocrinologie.